| Nov 6 |
Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge
|
| Nov 6 |
Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say
|
| Nov 6 |
Teva Pharmaceutical Industries Limited 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 6 |
Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report
|
| Nov 6 |
Teva gains after raising outlook for second time this year
|
| Nov 6 |
Teva Pharmaceutical beats Q3 top and bottom line estimates, raises outlook
|
| Nov 6 |
Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS
|
| Nov 5 |
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?
|
| Nov 5 |
Teva Pharmaceutical Q3 2024 Earnings Preview
|
| Nov 4 |
Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock?
|
